These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 22034751)

  • 1. [Menopausal hormone treatment in 2011].
    Rozenberg S; Vandromme J; Antoine C
    Rev Med Brux; 2011 Sep; 32(4):239-42. PubMed ID: 22034751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormone replacement therapy in the post-Women's Health Initiative era. Report a a meeting held in Funchal, Madeira, February 24-25, 2003.
    Burger H
    Climacteric; 2003 May; 6 Suppl 1():11-36. PubMed ID: 12945798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Menopause and stroke and the effects of hormonal therapy.
    Lobo RA
    Climacteric; 2007 Oct; 10 Suppl 2():27-31. PubMed ID: 17882669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New evidence regarding hormone replacement therapies is urgently required transdermal postmenopausal hormone therapy differs from oral hormone therapy in risks and benefits.
    Modena MG; Sismondi P; Mueck AO; Kuttenn F; Lignières Bd; Verhaeghe J; Foidart JM; Caufriez A; Genazzani AR;
    Maturitas; 2005 Sep; 52(1):1-10. PubMed ID: 15963666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Standard and low-dose hormone therapy for postmenopausal women--focus on the breast.
    Wang PH; Horng HC; Cheng MH; Chao HT; Chao KC
    Taiwan J Obstet Gynecol; 2007 Jun; 46(2):127-34. PubMed ID: 17638620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer risk in the WHI study: the problem of obesity.
    Kuhl H
    Maturitas; 2005 May; 51(1):83-97. PubMed ID: 15883113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteoporosis: new hope for the future.
    Masi L; Bilezikian JP
    Int J Fertil Womens Med; 1997; 42(4):245-54. PubMed ID: 9309458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WHI risks: any relevance to menopause management?
    Burger HG
    Maturitas; 2007 May; 57(1):6-10. PubMed ID: 17368974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of medroxyprogesterone acetate on estrogen-dependent risks and benefits--an attempt to interpret the Women's Health Initiative results.
    Kuhl H; Stevenson J
    Gynecol Endocrinol; 2006 Jun; 22(6):303-17. PubMed ID: 16785155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-menopausal hormone replacement therapy (cont'd): risk-benefit balance in the hot seat.
    Prescrire Int; 2004 Jun; 13(71):106-9. PubMed ID: 15233153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the need to clarify and disseminate contemporary knowledge of hormone therapy initiated near menopause.
    Langer RD
    Climacteric; 2010 Aug; 13(4):303-6. PubMed ID: 20540591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Climacteric: concept, consequence and care.
    Taechakraichana N; Jaisamrarn U; Panyakhamlerd K; Chaikittisilpa S; Limpaphayom KK
    J Med Assoc Thai; 2002 Jun; 85 Suppl 1():S1-15. PubMed ID: 12188398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postmenopausal hormone therapy: cardiovascular risks.
    Prescrire Int; 2003 Apr; 12(64):65-9. PubMed ID: 12674130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic features of menopausal and postmenopausal applicants for life insurance.
    Schiefeling M
    J Insur Med; 1996; 28(1):27-34. PubMed ID: 10172866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update: estrogen and estrogen plus progestin therapy in the care of women at and after the menopause.
    Davey DA
    Womens Health (Lond); 2012 Mar; 8(2):169-89. PubMed ID: 22375720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postmenopausal hormone therapy: from monkey glands to transdermal patches.
    Davis SR; Dinatale I; Rivera-Woll L; Davison S
    J Endocrinol; 2005 May; 185(2):207-22. PubMed ID: 15845914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Does menopause hormone therapy reduce the risk of chronic diseases?].
    Blümel JE; Arteaga E
    Rev Med Chil; 2018 Dec; 146(10):1170-1174. PubMed ID: 30724981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
    Genazzani AR; Gadducci A; Gambacciani M
    Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benefits and risks of long-term low-dose oral continuous combined hormone therapy.
    van de Weijer PH; Mattsson LA; Ylikorkala O
    Maturitas; 2007 Mar; 56(3):231-48. PubMed ID: 17034966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update: the latest on hormone replacement therapy.
    Packin GS
    J Am Osteopath Assoc; 2000 Oct; 100(10 Su Pt 1):S2-5. PubMed ID: 11105456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.